PDF file: EURASNET Annual Report 2008

CAREER DEVELOPMENT• Number of people moving between EURASNET laboratoriesTwelve short term visits (see report for WP18) in 2008.• Number of joint PhD students and postdocsAt least 12 cases.• Attendance at workshops/seminars on career development35 participants in the Krakow workshop.CONFERENCES AND MEETINGS• Number of participants during Annual Conference 2008Of the 40 research groups in the network, 34 were present with their respectiveprincipal investigator or an authorized legal representative. 38 additional lab membersattended the conference. Six of the seven Scientific Advisory Board members werepresent. The European Commission was represented by the external reviewer Prof.Philip Avner, Institut Pasteur, France and Scientific Officer Christina Kyriakopoulou.• Number of non-NoE participants during European ConferencesIn 2008 EURASNET organized the first International Conference on AlternativeSplicing in conjunction with the Annual reporting meeting in Krakow, Poland (185participants; about 80 non-Eurasnet). See the detailed meeting report.• Feedback from participants and SAB membersThe Annual Conference 2008 , as well as the IFMs and workshops all successfullybrought together participants and SAB members in the most fruitful way.EURASNET is increasingly recognized in the scientific community and industry as aserious player in AS-related research. The intellectual exchange within the network isconsidered very constructive and mutually beneficial.• Meeting reports in journals such as EMBO reportsA report on the 2007 Bariloche (Argentina) IFM appeared in EMBO reports 9, 516–520 (2008)• Attendance of Interdisciplinary Focus MeetingsFor detailed participant lists of EURASNET/non-EURASNET members we refer tothe respective detailed IFM reports: Montpellier 30 , Aarhus 34, Valencia 122• Attendance of Interdisciplinary Focus Meeting dedicated to splicing and diseaseFor a detailed participant list of EURASNET/non-EURASNET members (total 108)we refer to the respective detailed IFM report.SMEs AND TECHNOLOGY TRANSFER• Number of EURASNET links to industryAs a precondition for such links a commercialization fact-file was updated under theleadership of EURASNET member Angus Lamond, Dundee. He also prepared adocument " EURASNET Strategic Planning for the New Venture Biotechs" availablefor participants. Comments from legal departments of EURASNET memberscontinue to be evaluated and eventually incorporated into a new, updated version ofthe fact-file. The Dundee Cell Products Ltd (DCP) will discuss the potential for21